InvestorsHub Logo
Followers 14
Posts 3597
Boards Moderated 1
Alias Born 08/19/2015

Re: None

Saturday, 10/20/2018 10:56:20 AM

Saturday, October 20, 2018 10:56:20 AM

Post# of 470182
Another Hype PR from Dr Liar, pumper. IND is for safety study and dose dependency, FDA is concern with drug safety in children.

"Pharmacokinetic and dose finding will be investigated in a total of 15 patients over a 7-week treatment period including ANAVEX®2-73-specific genomic precision medicine biomarkers."...."This study will be followed by a planned placebo-controlled safety and efficacy evaluation of ANAVEX®2-73 over a 3 month treatment period" As usual next study will start in 2050.


Dr Liar is fooling investors with his pump but market has learned a lesson, it is not falling for his pump.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News